|
|
|
The Departmental Double Digit Impact Award
The Department of Biochemistry and Molecular Biology has recently initiated, from 2003 onwards, the "double digit impact award". Namely, the Department will award a bottle of wine to the laboratory who publishes a paper (primary research paper or review) in a journal with an impact factor greater than 10. The laboratory has to have either first or senior authorship. CHEERS
2008 (up to August 2008)
-
Godfrey, D.I., J. Rossjohn and J. McCluskey, REVIEW: The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity, 2008. 28(3): p. 304-14. Impact Factor: 19.266
-
Petrie, E.J., C.S. Clements, J. Lin, L.C. Sullivan, D. Johnson, T. Huyton, A. Heroux, H.L. Hoare, T. Beddoe, H.H. Reid, M.C. Wilce, A.G. Brooks and J. Rossjohn, CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med, 2008. 205(3): p. 725-35. Impact Factor: 15.612
-
Schessl, J., Y. Zou, M.J. McGrath, B.S. Cowling, B. Maiti, S.S. Chin, C. Sewry, R. Battini, Y. Hu, D.L. Cottle, M. Rosenblatt, L. Spruce, A. Ganguly, J. Kirschner, A.R. Judkins, J.A. Golden, H.H. Goebel, F. Muntoni, K.M. Flanigan, C.A. Mitchell and C.G. Bonnemann, Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest, 2008. 118(3): p. 904-912. Impact Factor: 16.915
-
Wimmer-Kleikamp, S.H., E. Nievergall, K. Gegenbauer, S. Adikari, M. Mansour, T. Yeadon, A.W. Boyd, N.R. Patani and M. Lackmann, Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood, 2008. 112(3) p. 721-732. Impact Factor: 10.896
-
Wun, K.S., N.A. Borg, L. Kjer-Nielsen, T. Beddoe, R. Koh, S.K. Richardson, M. Thakur, A.R. Howell, J.P. Scott-Browne, L. Gapin, D.I. Godfrey, J. McCluskey and J. Rossjohn, A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med, 2008. 205(4): p. 939-949. Impact Factor: 15.612
-
Wynn, K.K., Z. Marland, L. Cooper, S.L. Silins, S. Gras, J.K. Archbold, F.E. Tynan, J.J. Miles, J. McCluskey, S.R. Burrows, J. Rossjohn and R. Khanna, Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood, 2008. 111(8): p. 4283-4292. Impact Factor: 10.896
-
Wakabayashi, K., Z.X. Lian, P.S. Leung, Y. Moritoki, K. Tsuneyama, M.J. Kurth, K.S. Lam, K. Yoshida, G.X. Yang, T. Hibi, A.A. Ansari, W.M. Ridgway, R.L. Coppel, I.R. Mackay and M.E. Gershwin, Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology, 2008. 48(2): p. 531-540. Impact Factor: 10.734
-
Chessman, D., L. Kostenko, T. Lethborg, A.W. Purcell, N.A. Williamson, Z. Chen, L. Kjer-Nielsen, N.A. Mifsud, B.D. Tait, R. Holdsworth, C.A. Almeida, D. Nolan, W.A. Macdonald, J.K. Archbold, A.D. Kellerher, D. Marriott, S. Mallal, M. Bharadwaj, J. Rossjohn and J. McCluskey, Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity, 2008. 28(6): p. 822-32. Impact Factor: 19.266
-
Myers, M. and P. Zimmet, COMMENT: Halting the accelerating epidemic of type 1 diabetes. Lancet, 2008. 371(9626): p. 1730-1. Impact Factor: 28.683
-
Yang, G.X., Lian, Z.X., Chuang, Y.H., Moritoki, Y., Lan, R.Y., Wakabayashi, K., Ansari, A.A., Flavell, R.A., Ridgway, W.M., Coppel, R.L., Tsuneyama, K., Mackay, I.R., and Gershwin, M.E., Autoimmune, Cholestatic and Biliary Disease - Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology, 2008. 47(6): p. 1974-1982. Impact Factor: 10.734
-
Wall, M., Poortinga, G., Hannan, K.M., Pearson, R.B., Hannan, R.D., and McArthur, G.A., Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood, 2008. E-Pub. Impact Factor: 10.896
-
Shields, B.J., Hauser, C., Bukczynska, P., Court, N.W., and Tiganis, T., DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell, 2008. 14(2): p. 166-179. Impact Factor: 23.858
|